Eric Ferrari
- Hepatology top 1%
- Hepatitis C virus research 11
- Virology top 5%
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 7
- Viral gastroenteritis research and epidemiology 3
- Epidemiology top 5%
- Hepatitis B Virus Studies 8
- Herpesvirus Infections and Treatments 1
-
- Viral Infections and Immunology Research 5
-
- Biochemical and Molecular Research 2
-
- Virus-based gene therapy research 1
- Co-authors
- Zhi HongCharles A. LesburgMichael CablePatricia C WeberAnthony MannarinoJohnson Y. N. LauJacquelyn Wright-MinogueWeidong Zhong
- Journals
- Journal of Virology (5 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesSlovakiaIndia
In The Last Decade
Eric Ferrari
17 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Hepatology 864
- Virology 169
- Infectious Diseases 492
- Epidemiology 581
- Cardiology and Cardiovascular Medicine 323
Countries citing papers authored by Eric Ferrari
This map shows the geographic impact of Eric Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ferrari more than expected).
Fields of papers citing papers by Eric Ferrari
This network shows the impact of papers produced by Eric Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ferrari. The network helps show where Eric Ferrari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Ferrari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 4 | |
| 2 | 2017 | 2 | |
| 3 | 2013 | 3 | |
| 4 | 2010 | 20 | |
| 5 | 2010 | 16 | |
| 6 | 2008 | 25 | |
| 7 | 2000 | 97 | |
| 8 | 2000 | 162 | |
| 9 | Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models. | 1999 | 26 |
| 10 | 1999 | 597 | |
| 11 | 1999 | 210 | |
| 12 | 1999 | 94 | |
| 13 | 1997 | 27 | |
| 14 | 1997 | 3 | |
| 15 | 1997 | 45 | |
| 16 | 1996 | 22 | |
| 17 | 1996 | 76 |
About Eric Ferrari
Eric Ferrari is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Cardiology and Cardiovascular Medicine and Biotechnology, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (8 papers), HIV/AIDS drug development and treatment (7 papers), Viral Infections and Immunology Research (5 papers), Viral gastroenteritis research and epidemiology (3 papers), Biochemical and Molecular Research (2 papers), Virus-based gene therapy research (1 paper) and Herpesvirus Infections and Treatments (1 paper). The work is most often cited by research in Hepatology (864 citations), Virology (169 citations), Infectious Diseases (492 citations), Epidemiology (581 citations) and Cardiology and Cardiovascular Medicine (323 citations). Eric Ferrari has collaborated with scholars based in United States, Slovakia and India. Frequent co-authors include Zhi Hong, Charles A. Lesburg, Michael Cable, Patricia C Weber, Anthony Mannarino, Johnson Y. N. Lau, Jacquelyn Wright-Minogue, Weidong Zhong, Zhi Hong and Annette S. Uss. Their work appears in journals such as Journal of Virology, Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, Antiviral Research and Journal of Industrial Microbiology & Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.